01 May 2006
Interleukin-8 in the blood serum of patients with alcoholic liver disease.Renata Swiątkowska-Stodulska, Alicja Bąkowska, Anna Drobińska-Jurowiecka
Med Sci Monit 2006; 12(5): CR215-220 :: ID: 450291
Background: The influence of the immune system on the development of alcoholicliver disease has recently been the object of attention. However, the connection between alcohol consumption,altered immune response, and development of changes in the liver has not been fully explained. The aimof the present study was to evaluate serum IL-8 concentration in patients with chronic alcoholic liverdisease. Material/Methods: 85 patients with different types of ALD and 35 healthy subjects were enrolledin the study. Serum IL-8 concentration was evaluated with the ELISA immunoenzymatic method. IL-8 in livertissue was measured by the indirect immunofluorescence method. Results: There was a significant correlationbetween IL-8 concentration and AST, ALP, GGT, total bilirubin and albumin levels in blood serum. A significantlyhigher concentration of IL-8 was seen in all the groups of ALD patients. The highest values were foundin patients with chronic alcoholic hepatitis, and the lowest in those with fatty liver. Significantlyhigher values were found in patients with ascites or encephalopathy in comparison to those without anyfeatures of portal hypertension and/or insufficiency of the liver cells. A high concentration of thetested cytokine is a disadvantageous prognostic factor in patients with ALD. Conclusions: IL-8 appearsto be an important factor in liver pathology in patients with ALD, especially in the development of theinflammatory process.
Keywords: Case-Control Studies, Ascites - immunology, Enzyme-Linked Immunosorbent Assay, Fatty Liver, Alcoholic - immunology, Fluorescent Antibody Technique, Indirect, Hepatic Encephalopathy - immunology, Hepatitis, Alcoholic - immunology, Interleukin-8 - blood, Liver - immunology, Liver Cirrhosis, Alcoholic - immunology, Liver Diseases, Alcoholic - immunology, Prognosis
01 May 2023 : EditorialEditorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor Therapy
Med Sci Monit 2023; 29:e940911
31 May 2023 : Review articlePrevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical ResearchA Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...
Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review articleA Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...
Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database AnalysisThe COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952